Acelrx Pharmaceuticals Inc organizacji RPE

Jaka jest wartość RPE organizacji Acelrx Pharmaceuticals Inc?

Wartość RPE organizacji Acelrx Pharmaceuticals Inc to $13.522k

Jaka jest definicja RPE?

Przychód na pracownika (Revenue per employee - RPE) to przychód podzielony przez liczbę pracowników organizacji.

RPE firm w Health Care sektor na NASDAQ w porównaniu do Acelrx Pharmaceuticals Inc

Czym się zajmuję organizacja Acelrx Pharmaceuticals Inc?

acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v

Firmy z rpe podobne do Acelrx Pharmaceuticals Inc